Rights and permissions
About this article
Cite this article
Rosiglitazone reduces BP, increases insulin sensitivity in type 2 DM. Inpharma Wkly. 1458, 12 (2004). https://doi.org/10.2165/00128413-200414580-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200414580-00024